Retinal Disorder Treatment Global Market Report 2025

Description

Retinal disorder treatment encompasses medical interventions and procedures aimed at managing or improving the symptoms and conditions associated with retinal disorders. Retinal disorders involve abnormalities or damage to the retina, the light-sensitive tissue at the back of the eye responsible for transmitting visual signals to the brain.

The main types of retinal disorder treatment include macular degeneration, diabetic retinopathy, and others. Macular degeneration, often referred to as age-related macular degeneration (AMD), is a chronic eye condition primarily affecting the macula-the central area of the retina responsible for clear central vision. Treatment options are available in various dosage forms, including gels, eye solutions, capsules, tablets, eye drops, and ointments. These treatments are typically distributed through hospital pharmacies, online pharmacies, and retail pharmacies.

The retinal disorder treatment market research report is one of a series of new reports from The Business Research Company that provides retinal disorder treatment market statistics, including the retinal disorder treatment industry's global market size, regional shares, competitors with a retinal disorder treatment market share, detailed retinal disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the retinal disorder treatment industry. This retinal disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The retinal disorder treatment market size has grown strongly in recent years. It will grow from $12.59 billion in 2024 to $13.82 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to introduction of anti-vegf therapies, aging population, increased incidence of retinal disorders, improved diagnostic tools for early detection, increased awareness and screening programs, expanded access to healthcare services

The retinal disorder treatment market size is expected to see strong growth in the next few years. It will grow to $19.62 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to patient-centric approaches in retinal healthcare, increasing global healthcare expenditure, greater focus on combination therapies for retinal disorders, rise of home-based retinal disorder monitoring, increasing adoption of implantable devices for retina treatment, adoption of regenerative medicine in retina treatment. Major trends in the forecast period include advancements in ophthalmic imaging technologies, development of minimally invasive surgical techniques, integration of artificial intelligence in diagnostics, advancements in drug delivery technologies, integration of virtual reality in retinal rehabilitation, collaboration between research institutions and pharmaceutical companies, development of gene therapies for genetic retinal diseases.

The anticipated increase in the prevalence of retinal disorders is set to drive the expansion of the retinal disorder treatment market. Retinal diseases encompass medical conditions affecting the retina, the light-sensitive tissue at the back of the eye, and can lead to vision loss or severe visual impairment. Treatments for retinal disorders, including laser therapy, vitrectomy, and retinal implants, play a crucial role in managing and alleviating symptoms. As of January 2023, the International Agency for the Prevention of Blindness reports that age-related macular degeneration (AMD) is projected to account for approximately 5% of global blindness. The prevalence of AMD is expected to impact 288 million individuals by the year 2040. Thus, the rising incidence of retinal disorders is a significant driver for the growth of the retinal disorder treatment market.

The rising prevalence of diabetes is anticipated to drive the growth of the retinal disorder treatment market in the future. Diabetes is a chronic condition marked by high blood glucose levels, stemming from the body's insufficient insulin production or ineffective use of insulin. Diabetic retinopathy, the most common retinal disorder among people with diabetes, results from damage to the retina's blood vessels, potentially causing bleeding, fluid leakage, and the formation of new blood vessels. Retinal disorder treatments often use lasers to seal leaking vessels or remove abnormal ones. For instance, as reported by the International Diabetes Federation in December 2021, approximately 537 million adults aged 20-79 were living with diabetes in 2021, a figure projected to rise to 643 million by 2030 and 783 million by 2045. Thus, the growing prevalence of diabetes is fueling the expansion of the retinal disorder treatment market.

A notable trend gaining traction in the retinal disorder treatment market is the innovation of products by major companies. These innovations are introduced to maintain a competitive edge in the market. For example, in January 2022, F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland, received FDA approval for Vabysmo. Vabysmo is a bispecific antibody designed to treat neovascular or wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It represents the first injectable eye medication targeting and inhibiting two disease pathways, Angiopoietin-2 (Ang-2) and Vascular Endothelial Growth Factor-A (VEGF-A), associated with retinal diseases. Clinical trials demonstrated non-inferior vision improvements compared to traditional therapy, with a favorable safety profile.

Major companies in the retinal disorder treatment market are actively developing innovative products, including treatments for geographic atrophy, to expand their customer bases, boost sales, and increase revenue. Geographic atrophy treatments focus on symptom management, disease progression mitigation, and aiding individuals in coping with visual impairment. For instance, in August 2023, Astellas Pharma Inc., a Japanese pharmaceutical company, received FDA approval for IZERVAY. As a novel complement C5 inhibitor, IZERVAY is the sole approved treatment for geographic atrophy (GA) showing a statistically significant reduction (p<0.01) in the rate of GA progression in two Phase 3 clinical trials. This distinction positions IZERVAY as an effective therapy for GA secondary to age-related macular degeneration (AMD).

In July 2023, Astellas Pharma Inc. acquired Iveric Bio Inc., a biopharmaceutical company based in the United States, for an undisclosed amount. This strategic acquisition is aimed at expanding Astellas' presence in ophthalmology, gaining access to innovative therapies for retinal diseases, and enhancing its position in the market for treating ophthalmologic conditions and vision loss.

Major companies operating in the retinal disorder treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd, Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV

North America was the largest region in the retinal disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the retinal disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The retinal disorder treatment market includes revenues earned by entities by providing retinal detachment, laser treatment, genetic treatments, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Retinal Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on retinal disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for retinal disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The retinal disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Macular Degeneration; Diabetic Retinopathy; Other Types
2) By Dosage Form: Gels; Eye Solutions; Capsules And Tablets; Eye Drops; Ointments
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Macular Degeneration: Dry Macular Degeneration; Wet Macular Degeneration
2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy; Proliferative Diabetic Retinopathy
3) By Other Types: Retinal Detachment; Retinitis Pigmentosa; Uveitis; Other Retinal Disorders
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25269

1. Executive Summary

2. Retinal Disorder Treatment Market Characteristics

3. Retinal Disorder Treatment Market Trends And Strategies

4. Retinal Disorder Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Retinal Disorder Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Retinal Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Retinal Disorder Treatment Market Growth Rate Analysis
5.4. Global Retinal Disorder Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Retinal Disorder Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Retinal Disorder Treatment Total Addressable Market (TAM)

6. Retinal Disorder Treatment Market Segmentation

6.1. Global Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Macular Degeneration
Diabetic Retinopathy
Other Types
6.2. Global Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gels
Eye Solutions
Capsules And Tablets
Eye Drops
Ointments
6.3. Global Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.4. Global Retinal Disorder Treatment Market, Sub-Segmentation Of Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dry Macular Degeneration
Wet Macular Degeneration
6.5. Global Retinal Disorder Treatment Market, Sub-Segmentation Of Diabetic Retinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
6.6. Global Retinal Disorder Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retinal Detachment
Retinitis Pigmentosa
Uveitis
Other Retinal Disorders

7. Retinal Disorder Treatment Market Regional And Country Analysis

7.1. Global Retinal Disorder Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Retinal Disorder Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Retinal Disorder Treatment Market

8.1. Asia-Pacific Retinal Disorder Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Retinal Disorder Treatment Market

9.1. China Retinal Disorder Treatment Market Overview
9.2. China Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Retinal Disorder Treatment Market

10.1. India Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Retinal Disorder Treatment Market

11.1. Japan Retinal Disorder Treatment Market Overview
11.2. Japan Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Retinal Disorder Treatment Market

12.1. Australia Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Retinal Disorder Treatment Market

13.1. Indonesia Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Retinal Disorder Treatment Market

14.1. South Korea Retinal Disorder Treatment Market Overview
14.2. South Korea Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Retinal Disorder Treatment Market

15.1. Western Europe Retinal Disorder Treatment Market Overview
15.2. Western Europe Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Retinal Disorder Treatment Market

16.1. UK Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Retinal Disorder Treatment Market

17.1. Germany Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Retinal Disorder Treatment Market

18.1. France Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Retinal Disorder Treatment Market

19.1. Italy Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Retinal Disorder Treatment Market

20.1. Spain Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Retinal Disorder Treatment Market

21.1. Eastern Europe Retinal Disorder Treatment Market Overview
21.2. Eastern Europe Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Retinal Disorder Treatment Market

22.1. Russia Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Retinal Disorder Treatment Market

23.1. North America Retinal Disorder Treatment Market Overview
23.2. North America Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Retinal Disorder Treatment Market

24.1. USA Retinal Disorder Treatment Market Overview
24.2. USA Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Retinal Disorder Treatment Market

25.1. Canada Retinal Disorder Treatment Market Overview
25.2. Canada Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Retinal Disorder Treatment Market

26.1. South America Retinal Disorder Treatment Market Overview
26.2. South America Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Retinal Disorder Treatment Market

27.1. Brazil Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Retinal Disorder Treatment Market

28.1. Middle East Retinal Disorder Treatment Market Overview
28.2. Middle East Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Retinal Disorder Treatment Market

29.1. Africa Retinal Disorder Treatment Market Overview
29.2. Africa Retinal Disorder Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Retinal Disorder Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Retinal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Retinal Disorder Treatment Market Competitive Landscape And Company Profiles

30.1. Retinal Disorder Treatment Market Competitive Landscape
30.2. Retinal Disorder Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Retinal Disorder Treatment Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Company Limited
31.2. Regeneron Pharmaceuticals Inc.
31.3. Bausch Health Companies Inc.
31.4. Genentech Inc.
31.5. Santen Pharmaceutical Co. Ltd.
31.6. Apellis Pharmaceuticals Inc.
31.7. Kubota Pharmaceutical Holdings Co. Ltd
31.8. Alimera Sciences Inc.
31.9. Ocular Therapeutix Inc.
31.10. EyePoint Pharmaceuticals Inc.
31.11. Adverum Biotechnologies Inc.
31.12. Kodiak Sciences Inc.
31.13. Acucela Inc.
31.14. IVERIC bio Inc.
31.15. Oxurion NV

32. Global Retinal Disorder Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Retinal Disorder Treatment Market

34. Recent Developments In The Retinal Disorder Treatment Market

35. Retinal Disorder Treatment Market High Potential Countries, Segments and Strategies

35.1 Retinal Disorder Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Retinal Disorder Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Retinal Disorder Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer